Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2013Cochrane libraryOpen Access

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMichaela RanceaUniversity Hospital CologneIMIna MonsefUniversity Hospital CologneBTBastian von TresckowHeidelberg University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rancea et al. (2013) studied this question.

synapsesocial.com/papers/6a7bf0c924f98b6d3fc2a3cfhttps://doi.org/10.1002/14651858.cd009411.pub2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Standard therapy of advanced Hodgkin lymphoma2009 · 85 citations
  2. 2Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma2007 · 233 citations
  3. 3Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study2001 · 72 citations